14
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Hla-Dpb1 Polymorphisms in Patients with Hyperthyroid Graves' Disease and Early Onset Myasthenia Gravis

, , , , , & show all
Pages 99-104 | Received 02 Nov 1993, Published online: 07 Jul 2009
 

Abstract

Using the technique of in vitro enzymatic DNA amplification and dot blot hybridization with sequence-specific oligonucleotide (SSO) probes, a study of genetic polymorphism of HLA-DPB1 was performed in 83 unrelated patients with Graves' disease (GD), 48 patients with early onset myasthenia gravis (EOMG) and 100 normal British caucasoid subjects who were also tissue typed for HLA-A, B and DR antigens. HLA-DPB 1*0401 was the commonest allele in both patient and control groups with gene frequencies of 0.380, 0.333 and 0.445 for GD, EOMG and controls, respectively. No significant independent association was found with any HLA-DPB 1 allele. As expected, HLA-DR17 is significantly associated with Graves' disease (pc < 8 × 10-3, RR = 2.9), while both HLA-B8 and DR17 are significantly associated with EOMG (pc < 2 × 10-7, RR= 10.3 and pc < 0.02, RR = 3.4, respectively)] HLA-DR2 is also significantly increased in EOMG patients who were negative for HLA-DR17 (pc < 0.02, RR = 6.4). In addition, the co-occurrence of HLA-B8 with DPB 1*0402 was significantly commoner in patients with GD (p < 0.021, RR = 6.2) and EOMG (p <0.0007, RR = 10.8) than in controls, although the HLA-DPB 1 *0402 by itself showed no significant increase.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.